Clinical studies recruiting near Inverness

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
Phase 3 · Raigmore Hospital · The University of Queensland · NCT04939935 The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NA · Raigmore Hospital · University of Leicester · NCT04204915 A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Phase 3 · Nature Coast Clinical Research - Inverness · Eli Lilly and Company · NCT07282600 PRC With Meniscal Allograft Arthroplasty for Wrist Osteoarthritis
NA · University of Colorado, Denver · NCT05412615 Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
NA · NHS Highland · The University of Queensland · NCT03573089 Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial
Phase 2/Phase 3 · NHS Highland Clinical Research Facility, Raigmore Hospital · University of Edinburgh · NCT04302870 Registry for Patients With X-Linked Hypophosphatemia
Phase N/A · Raigmore Hospital · Kyowa Kirin Pharmaceutical Development Ltd · NCT03193476 Renal Adjuvant MultiPle Arm Randomised Trial
Phase 3 · Raigmore Hospital · University College, London · NCT03288532 A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT07221188 A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Nature Coast Clinical Research ( Site 1045) · Merck Sharp & Dohme LLC · NCT07463183 A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06215716 Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Phase 2 · Nature Coast Clinical Research - Inverness /ID# 265874 · AbbVie · NCT06548542 iCorMicA - Stratified Medicine in Angina
NA · Raigmore Hospital · NHS Greater Glasgow and Clyde · NCT04674449 A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg)
Phase 3 · Investigational Site Number : 8260003 · Sanofi · NCT06290141 A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a
Phase 3 · Research Site · AstraZeneca · NCT07000357 A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
Phase 3 · Raigmore Hospital · King's College London · NCT06461208 A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Col
Phase 3 · Nature Coast Clinical Research · Janssen Research & Development, LLC · NCT07196748 A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Phase 3 · Raigmore Hospital · Novo Nordisk A/S · NCT07567001 A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT07221227 Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 3 · Raigmore Hospital · Eli Lilly and Company · NCT07157774 Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Phase 3 · Nature Coast Clinical Research · Amgen · NCT07037459 ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Po
Phase 2 · Nature Coast Clinical Research - Inverness · Calico Life Sciences LLC · NCT06902558 A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Ag
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06517758 The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
Phase 3 · Raigmore Hospital · University of Leeds · NCT03562169 A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-L
Phase 3 · Raigmore Hospital · Amgen · NCT05920356 A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Phase 2/Phase 3 · Nature Coast Clinical Research · Janssen Research & Development, LLC · NCT07196722 A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Ou
Phase 3 · Nature Coast Clinical Research - Inverness · Eli Lilly and Company · NCT07165028 Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy
NA · Raigmore Hospital - NHS Highland · University Hospitals of Derby and Burton NHS Foundation Trus · NCT04109079

Look up another city

Look up another condition